Researchers from Manchester and Melbourne assess the impact of high drop-out rates on Cochrane reviews of five frequently prescribed second-generation antipsychotics. They found that all five reviews misrepresented the available evidence by including data from studies with unacceptable levels of attrition, often without any acknowledgment or justification. Results will appear in Acta Psychiatrica Scandinavica.
